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Abstract 
Invalidation is defined as the perception of cognitive, affective, and behavioral responses of 
others that are experienced as denying, lecturing, overprotecting, not supporting, and not 
acknowledging with the respect to the condition of the patient (Kool, 2012). Invalidation has also 
been suggested to negatively impact patients’ physical health (Kool, 2012). One specific type of 
invalidation is illness invalidation (II), defined as attitudes of distrust, suspicion, lack of support 
for, or acknowledgement that a patient is suffering from an illness (Blom et al., 2011). In 
addition to II, illness perception (IP) is another construct that has been linked to negative 
physical health (Arran, Carufurd, & Simpson, 2013). IP is a process through which an individual 
constructs a cognitive representation of an illness and has also been shown to influence symptom 
severity and physical functioning (Arran et al., 2013). Although the relationships between II, IP, 
and physical health have been observed previously, more extensive research is needed to 
determine the specific mechanisms of these relationships and what other psychological factors 
may play a role. Previous studies indicate that coping behaviors and depressive symptoms may 
be factors that influence these relationships (Shen, McCreay, & Myers, 2003). The present study 
used a regression analysis to reveal that depression was the only significant predictor of physical 
functioning. The present study also used PROCESS (Hayes, 2013) to reveal that depression 
mediated the relationship between IP and physical functioning, but did not mediate the 
relationship between II and physical functioning. The present study also revealed that coping did 
not mediate the relationship between IP and physical functioning, nor did coping mediate the 
relationship between II and physical functioning. Lastly, the present study revealed that II and IP 
were both significantly related to depression, and IP was significantly related to II.  	
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Examining	II	and	IP	in	Relation	to	Physical	Functioning	in	the	Context	of	Cardiovascular	Disease	
	
Cardiovascular disease is currently the leading global cause of death, accounting for 17.3 
million deaths per year (American Heart Association, 2015). Since 1921, cardiovascular disease 
has been the leading cause of death in the United States and currently accounts for over 375,000 
American deaths per year (Howarter, Bennett, Barber, Gessner, & Clark, 2014). By the year 
2020, the World Health Organization predicts that cardiovascular disease and major depression 
will become the two leading contributors to the global burden of disease, and that cardiovascular 
disease alone will account for more than 23.6 million deaths per year by the 2030 (Ali, Rollman, 
& Berger, 2010). A widespread amount of recent literature has established that psychosocial 
factors significantly contribute to the pathogenesis of coronary artery disease (Rozanski, 
Blumenthal, & Kaplan, 2014). The prevalence of comorbid mental health conditions in cardiac 
patients is well documented with many studies associating psychological risk factors with a poor 
prognosis for heart diseases (Ali et al., 2010). This extensive knowledge has also contributed to 
the illumination of the basic pathophysiology that underlies the relationship between 
psychosocial factors and development and severity of heart disease (Rozanski et al., 2014). 
However, the identification of psychological predictors for coronary heart disease has produced 
inconsistent results (Rugulies, 2002). Despite many encouraging findings, there has been 
insufficient research exploring the interrelationships among some of these conceivable related 
psychosocial variables and how they may affect the outcomes of coronary heart disease (Shen et 
al., 2003).  
Depression and Cardiovascular Disease Prognosis 
Perhaps the most widely studied psychosocial factor in relation to cardiovascular disease 
is depression. In this paper, depression refers to unipolar clinical depression as diagnosed by 
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clinical assessment, and depressed mood as measured by standardized self-report scale. 
Depression has been found to be an independent risk factor in the etiology of coronary heart 
disease and the risk of coronary heart disease has been found to be directly related to the severity 
of depression (Goldston & Baillie, 2008). Comorbid depression is relatively common in patients 
with coronary heart disease, as approximately one in five patients with newly diagnosed heart 
disease has major depression (Carney, Freedlan, Miller, & Jaffe, 2002). The prevalence of major 
depression is similar in patients recovering from acute myocardial infarction and other acute 
cardiac stresses and once coronary heart disease is established, depression has a negative overall 
impact on the prognosis of the disease, increasing both the risk of occurrence of future cardiac 
events and higher risk of mortality (Goldston & Baillie, 2008). The presence of depressive 
symptoms even in the absence of diagnosed major depressive episodes is associated with 
increased risk for cardiac events, and a number of studies confirm a relationship between the 
magnitude of depression and future cardiac events (Rozanski et al., 2014). This data suggests 
that risk for future cardiac disease associated with depression exists along a continuum relative to 
the magnitude of depressive symptoms (Rozanski et al., 2014).  
There are many proposed mechanisms to explain the relationship between depression and 
severity of physical symptoms in patients with cardiac disease. Some plausible explanations for 
the relationship between depression and cardiac mortality and morbidity include biological 
mechanisms such as antidepressant cardiotoxicity and dysregulation of autonomic, 
neuroendocrine, and seratonergic systems (Carney et al., 2002). More specifically, depression 
has been associated with hyperactivity of the hypothalamic-pituitary-adrenocortical (HPA) axis, 
which results in over-stimulation of the sympathetic nervous system, which then increases 
circulating catecholamines and serum cortisol (Goldston & Baillie, 2008). These neurohormonal 
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abnormalities contribute to an imbalance in sympathetic and parasympathetic activity, which 
results in surges in heart rate and systolic blood pressure, increasing the risk of atherosclerotic 
plaque rupture and acute coronary thrombosis (Goldston & Baillie, 2008).  
 According to Rozanski et al. (2014), direct pathophysiological effects of depression 
involve at least three mechanisms. The first is that depression is accompanied by 
hypercortisolemia, which is associated with attenuation of the adrenocorticotropin hormone 
response to corticotropin-releasing factor administration, non-suppression of cortisol secretion 
after dexamethasone administration, and elevated corticotropin releasing factor concentrations in 
the cerebrospinal fluid, all of which contribute to more severe symptoms of heart disease. A 
second mechanism proposed by Rozanski et al. is that due to the association between depression 
and unhealthy lifestyle behaviors, depressed patients may develop substantial impairment in 
platelet function. This impairment can include augmented platelet reactivity and release of 
platelet products including platelet factor 4 and b-thromboglobulin, which are associated with 
adverse cardiovascular events. The mixture of hypercortisolemia and enhanced platelet function 
establishes the theoretical basis to explain the proatherogenic effects of depression (Rozanski et 
al., 2014). Lastly, reduced heart rate variability (HRV) and impaired vagal control have been 
reported in cardiac patients suffering from depression. HRV is a widely used noninvasive 
measure that reflects the autonomic regulation of the heart and is measured by beat-to-beat 
changes in a patient’s heart rate (Hoogwegt et al., 2014). Reduced HRV is a well-known 
predictor of cardiac mortality, including sudden cardiac death resulting from ventricular 
fibrillation. This finding also supports the assertion that depressed patients may be subject to 
increased risk for cardiac arrhythmia, further contributing to severity of cardiac related 
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symptoms. Therefore, HRV might be an important explaining mechanism of the relationship 
between psychological distress and prognosis (Hoogwegt et al., 2014). 
Depression may also contribute to the onset or worsening of cardiovascular disease by 
triggering recurrent endothelial injuries (Carney et al., 2002). The endothelium is the key 
regulator of homeostasis in the vascular tissue, and alteration in endothelial function precedes the 
development of atherosclerosis in patients (Deanfield, Halcox, & Rabelink, 2015). This could 
occur via promotion of maladaptive health processes, triggering dysregulation of the 
neurohormonal systems responsible for cortisol and catecholamine secretion, or increasing 
susceptibility to infection with latent pathogens that colonize the vessel wall (Herbert & Cohen, 
1993; Miller, Cohen, & Herbert, 1999; Plotsky, Owens, & Nemeroff, 1995). Furthermore, in 
consideration of behavioral mechanisms, depression is associated with unhealthy lifestyle 
behaviors including smoking and poor compliance with medication, which have been shown to 
contribute to the worsening function of these biological processes and, thus, increased rates of 
morbidity and mortality in patients with cardiovascular disease (Rozanski et al., 2014). In order 
to investigate the relationship between depression and physical function in the present study, a 
regression analysis was used.  
Coping and Cardiovascular Disease Prognosis 
As previously mentioned, psychological interventions for cardiac patients have mostly 
focused on depression factors, selecting patients for treatment based on the type and severity of 
symptoms displayed (Chiavarino et al., 2012). One general shortcoming of all symptom-based 
approaches is that they do not address, and are not concerned with, the ways that individuals 
attribute meaning to the events that happen to them. Research findings indicate that the well-
being of chronically ill patients is not only determined by medical factors such as disease 
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severity, but that psychological factors such as coping strategies patients adopt play a crucial role 
in physical recovery (Kaptein et al., 2006). Penninx et al. (1998) revealed that personal coping 
resources were directly associated with less depressive symptoms in patients. Furthermore, 
Hoogwegt et al. (2013) found that emotional distress that results from an inability to cope has 
been associated with cardiac events and poor prognosis in cardiovascular patients. In patients 
with coronary artery disease, emotional distress is known to increase the risk of ventricular 
arrhythmias and mortality independent of biomedical risk factors (Hoogwegt et al., 2013).  
In contrast to symptom-based treatment approaches, constructive approaches emphasize 
the structure of human experience and focus on the emotions, thoughts, and behavioral strategies 
that lead an individual to develop a certain symptom rather than on the symptom itself 
(Chiavarino et al., 2012). In other words, constructive approaches focus on specific coping 
strategies that may lead to depressive symptomatology, and thus the severity of cardiac 
symptoms. Consistent with this way of thinking, it has been demonstrated that coping strategies 
following a cardiac event can influence psychological well-being or distress (i.e., depression), 
perceived quality of life, and health-related behaviors, which can in turn influence the severity of 
the patient’s cardiovascular disease (Chiavarino et al., 2012). 
Coping with illness involves both cognitive and behavioral efforts to manage the external 
or internal demands that are appraised as taxing or surpassing individual resources (Fan, Eiser, 
Ho, & Lin, 2012). There are two kinds of coping behaviors that have been defined: problem-
focused coping, a behavior in which the individual attempts to manage the stressor or solve the 
problem, and emotion-focused coping, a behavior in which the individual attempts to regulate 
the emotional response that is induced by the stressor (Folkman et al., 1986). People tend to use 
problem-focused approaches when they believe that their resources or the demands of the 
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situation are changeable, and people tend to use emotion-focused coping when they believe they 
can do little to change the stressful conditions (Sarafino & Smith, 2011). However, some coping 
strategies can ultimately have negative effects. For example, avoidance as an emotion-focused 
coping strategy is a specific emotional coping behavioral technique in which the individual 
attempts to avoid dealing with the stressor at all. This strategy can be helpful for the individual in 
the short-term, but using avoidance strategies to cope two to three weeks after the stressor 
occurred has been associated with higher levels of emotional distress (Dunkel-Schetter, 
Feinstein, Taylor, & Falke, 1992). Emotional coping strategies that acknowledge the stressor, 
including positive reappraisal and actively processing emotions, have been found to be 
associated with an overall trend of better adaptation and management of problems in individuals 
(Fan et al., 2012).  
It has been suggested in the cardiological field that emotion-focused coping strategies 
which are directed at managing one’s emotional reactions to a stressor or event are especially 
important and effective in the time following a cardiac event (Chiavarino et al., 2012). 
Chiavarino et al. (2012) found emotion-focused coping strategies at the time of a cardiac event 
were a reliable predictor of disease severity at a three-month follow up. Sul and Fletcher (1985) 
also found that active problem-focused coping was found to result in more benign long-term 
outcomes. Another study found that avoidant coping was associated with a widespread 
psychological distress among cardiac patients, including depression (Ali et al., 2010). Behavioral 
research has also shown that hope and adaptive coping can help alleviate symptoms and improve 
outcomes in patients with cardiac disease (Ali et al., 2010). Demonstrating that patients’ coping 
strategies after a cardiac event are more strongly associated with future disease severity than 
expressed symptomatology supports an emphasis on individuals using the constructive 
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perspective to make sense of the events that happen to them and deal with these events 
(Chiavarino et al., 2012). Consistent with the previously mentioned analysis method used to 
investigate the relationship between depression and physical function, a regression analysis was 
also used in the present study in order to investigate the relationship between coping and 
physical functioning in a cardiac rehabilitation population.  
Invalidation and Cardiovascular Disease Prognosis 
A copious amount of literature has revealed that in addition to personal coping resources, 
social support may also contribute to variability in the impact of chronic illness (Penninx et al., 
1998). The robust association of social support and health status has been well-documented 
(Case et al., 2002). In a study of depression among patients in cardiac rehabilitation, Holohan et 
al. (1997) found that more perceived social support was associated with active coping, which in 
turn was related to lower depressive symptomatology. Depressed patients have also been found 
to be less likely to utilize social support resources available to them (Berkman, 1995). As 
previously mentioned, depressive symptomatology in turn was associated with worse health 
outcome in cardiac patients and an increased likelihood of experiencing angina, maintaining 
smoking habits, and a failure to return to work (Shen, McCreary, & Myers, 2003). Shen et al. 
(2003) discovered that social support was a direct independent predictor of post-treatment 
physical functioning in cardiac rehabilitation patients. Individuals with higher perceived social 
support were less likely to engage in detrimental coping and experienced less mood disturbance.  
Social support, like many other psychosocial factors, influences the extent to which 
individuals engage in high risk behaviors and maladaptive coping mechanisms such as smoking, 
poor diet, and excessive alcohol use (Penninx et al., 1998). Social support factors have also been 
shown to have direct pathophysiological effects (e.g., hypercortisolemia; Rozanski et al., 1999). 
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Initial studies focused on the quantitative aspects of social support, including the presence of 
family affiliations, amount of friends, and scope of participation in a group or organization 
(Rozanski et al., 1999). However, the qualitative nature of social support (i.e., perceived amount 
of social support) has been increasingly subject to study.  
The support received from others can be fundamental in helping to improve the quality of 
life in patients suffering from chronic disease (Kool, 2012). People are social beings for whom 
positive interactions as well as supportive communication are important. In other words, people 
hold a deep-seated need to belong and to be socially accepted (Bediako & Friend, 2004). 
However, many patients not only experience a lack of social support, but a lack of understanding 
as well. In these cases, people in the social environment may accuse the patient of being whiny 
or exaggerating the severity of his or her symptoms, and may tell the patient that (s)he should 
work harder, stop complaining, and feel better. In this case, the term invalidation is used to 
capture the construct that refers to such negative rejections (Kool, 2012).  
It is important to note that invalidation is not simply the opposite of social support. 
Invalidation is a social phenomenon that is determined by not only the provider of the 
invalidation, but the perceiver as well. Several studies have shown that invalidation may arise 
from different sources, including spouses, colleagues, health professionals, and society, and can 
hinder the interaction of patients with other people (Ghavidel-Parsa et al., 2014). Invalidation can 
be reflected in an individual’s overall perception of emotional, behavioral, and cognitive 
responses from others. Kool et al. (2012) also found that from the perspective of the patients, 
invalidation not only includes lack of understanding and denying, but also lecturing and 
overprotecting. Therefore, invalidation can be more specifically defined in a healthcare setting as 
“the perception of cognitive, affective, and behavioral responses of others that are experienced as 
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denying, lecturing, overprotecting, not supporting, and not acknowledging with respect to the 
condition of the patient” (Kool et al., 2012, p.30).  
II is one type of invalidation that plays a role in patients’ overall health status. II can be 
defined as attitudes of distrust, suspicion, lack of support for, or acknowledgement that a patient 
is suffering from an illness (Blom et al., 2011). Lobo et al. (2014) suggested that constant 
invalidation of symptoms may serve as a barrier in effective management of pain and its 
associated symptoms, and may also interfere with shared decision making processes regarding 
patient treatment. Due to complexity and variance of many symptoms of chronic illness, the 
process of diagnosis and treatment can be frustrating for patients as well as physicians. Previous 
studies have indicated that patients suffering from chronic illness could benefit from empathy, 
trust, and recognition of their disorder (Blom et al., 2011). Invalidation of the illness and 
symptoms can cause disbelief about the patient’s presenting problems, which can result in 
misunderstanding, rejecting, and discounting by others and suspicion that the symptoms are 
either exaggerated or have a psychological basis (Ghavidel-Parsa et al., 2014). Previous studies 
have also provided evidence that fewer experiences of II have been associated with a higher 
quality of life for patients, which can result in less severe depressive symptoms (Lobo et al., 
2014). Research suggests that II can also weaken a patient’s ability to solve interpersonal and 
emotional difficulties, which can affect their overall quality of life (Blom et al., 2011). Study 
findings from Lobo et al. (2014) also demonstrate that II may have a detrimental effect on health 
outcomes and overall quality of life. This study specifically showed that invalidation of patients’ 
physical symptoms could have an impact on self-development, relationships with others, and 
interactions with society, which may further manifest into depressive symptoms and impact 
physical functioning.  
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It is suggested that in addition to having a negative effect on mental well-being, 
invalidation may impact physical health and social function (Ghavidel-Parsa et al., 2014). It also 
has been shown to decrease social support and increase social rejection (Kool et al., 2009). 
According to social support theory, social support advances health and buffers the impact of 
external stressors on health, implying that a lack of social support may be associated with worse 
health (Bediako & Friend, 2004). These findings suggest that invalidation would have a negative 
impact on patients’ health as well, as invalidation is not only a lack of social support, but overt 
rejection and not being acknowledged. This invalidation is in direct contrast to having social 
support where one would receive positive and helpful responses such as affection, information, 
instrumental aid, and spending positive time with others (Laidmäe, Leppik, Tulva, & Hääl, 
2009). In fact, it has been suggested that invalidation might be more harmful than not receiving 
social support in patients, because invalidation can lead to higher levels of non-disclosure of the 
illness, social isolation, a decrease of health care adherence and treatment, and changes in 
cognition that may affect a patient’s health (Rokach, Lechcier-Kimel, & Safarov, 2006). 
Therefore, besides simply a lack of positive social interactions, invalidation may have a 
complementary negative effect on patients’ well-being and overall physical functioning (Kool, 
2012).  
Further evidence indicates that more discounting by a patient’s social network may be 
associated with worse mental well-being and worse physical functioning, and that the more 
invalidation patients experience, the greater the disease impact and the greater the symptom 
severity (Ghavidel-Parsa et al., 2014). Invalidation includes a lack of positive social responses, 
and these positive social responses are thought to directly promote health and buffer the impact 
of external stressors on health. Invalidation may also be harmful to patient’s health for additional 
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reasons other than a lack of social support. Invalidation includes an active component of social 
rejection, which has been indicated in past research to amplify pain via activation of neural 
structures such as the anterior cingulated cortex (Kurzba & Leary, 2001). Research suggests that 
focusing on patients’ perception of invalidation may lead to improvements in physical health, 
and that experimental research should examine effects of not only promoting social support, but 
decreasing invalidation (Kool, 2012).  
The specific mechanisms of how II relates to worsening physical functioning continue to 
remain unknown. However, it has been shown that patients who feel invalidated are more likely 
to distance themselves from others and become socially isolated, which often leads to 
depression, which has a known effect on the severity of physical functioning (Rokach et al., 
2006). Patients who experience invalidation also sometimes withdraw from traditional medical 
care instead of adjusting to their illness (Kool, 2012). This avoidant coping has also been shown 
to contribute to higher levels of emotional distress, and thus may contribute to worsening 
physical symptoms. Consistent with the previously stated method of analyses used to investigate 
the relationship between depression and physical function, and coping and physical function, a 
regression analysis was also used in the present study in order to investigate the relationship 
between II and physical functioning in a cardiac rehabilitation population. 
IP and Cardiovascular Disease Prognosis 
Another important psychological factor that may influence symptom severity and 
physical functioning in cardiac patients is the level of IP. IP is a process through which an 
individual constructs a cognitive representation of an illness and has also been shown to 
influence symptom severity and physical functioning in cardiac patients (Arran, Carufurd, & 
Simpson, 2013). According to the common sense model, patients actively process, understand, 
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and interpret information related to their health status or illness (Fan, Eiser, Ho, & Lin, 2012). 
Patients’ representations of their illness are based on beliefs about the following five 
components: identity (referring to the label or nature of the condition), causal beliefs (beliefs 
about the causes of their disease), timeline (duration of their disease), consequences (the impact 
of their disease on their life), and cure (whether the disease is amenable to cure or control). There 
are two parallel-processing pathways including cognitive representations and emotional 
responses to their illness. Using these representations, patients plan and implement coping 
behaviors in order to manage their health related problems (Fan et al., 2012).  
 Arran, Carufurd, and Simpson (2013) found that IPs were positive predictors of 
depression and that IPs play a significant role in levels of psychological distress, thus 
contributing to worsening physical symptoms. One model that is widely used in the field of 
chronic illness that best illustrates the relationship between IP and depression is the self-
regulation model. Self-regulation describes the process through which an individual constructs a 
cognitive representation of an illness, selects a coping strategy in response to the perceived 
threat, and evaluates its effectiveness and outcome (Arran et al., 2013). These representations 
directly influence the coping behaviors utilized by the individual and, consequently, that 
individual’s emotional response to the illness. In short, the self-regulation model postulates that 
an individual chooses coping strategies based on their own perceptions of the illness. This 
combination of IPs and coping strategies is thought to influence the person’s emotional reaction 
to the illness, contributing to the level of psychological distress, such as depression (Arran et al., 
2013). As previously discussed, depressive symptomatology is an established predictor of a 
worse prognosis and increased severity of symptoms in cardiac patients. This implies that coping 
mechanisms selected by the patient based on his or her perception of the illness may be 
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responsible for increased amounts of depressive symptoms, which may then negatively influence 
the patient’s physical health.  
Studies have shown that when patients perceived their disease to be controllable, the 
majority used cognitive strategies such as reappraisal and problem-focused coping in order to 
manage their problems (Kaptein et al., 2006). Patients who perceive that their disease will have a 
low impact on their quality of life have been shown to have better adjustment outcomes to 
coping with their disease (Hagger & Orbell, 2003).  The interaction of problem-focused coping 
and perceived control has also been found to be a significant predictor of depression, as patients 
who perceived higher levels of control and used problem-solving coping had lower levels of 
depression than those who did not (Osowiecky & Compas, 1998). However, the question still 
remains whether IPs influence well-being via coping, or whether IPs and coping each influence 
well-being independently (Kaptein et al., 2006). Consistent with all other previously mentioned 
methods of analyses, a regression analysis was also used in the present study in order to 
investigate the relationship between IP and physical functioning in a cardiac rehabilitation 
population.  
Present Study 
 In consideration of previous empirical evidence, the present study sought to better 
understand the specific ways that II and IP contribute to the severity of physical symptoms in 
cardiovascular rehabilitation patients. This study aimed to examine the specific mechanisms 
involved in the relationship between II and physical functioning in cardiac rehabilitation patients 
and the specific mechanisms involved in the relationship between IP and physical functioning in 
cardiac rehabilitation patients. More specifically, the present study focused on how II and IPs are 
each individually related to coping behaviors and depressive symptoms, and how those behaviors 
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and symptoms relate to the patient’s physical functioning. The present study had two primary 
goals: First, to identify the strength of the relationships between IP and physical functioning and 
II and physical functioning upon enrollment in the rehabilitation program. Second, the present 
study sought to identify the role, if any, that coping behaviors and depressive symptoms play in 
these relationships. Thus, due to the comprehensive purpose of this study, the following 
hypotheses were proposed:  
 Hypothesis 1: Physical functioning (as measured by a composite score of the SF-36, 
heart rate, body mass index, and systolic blood pressure) will be significantly predicted by II 
scores (as measured by scores on the Illness Invalidation Inventory), IP scores (as measured by 
the Illness Perception Questionnaire), positive coping strategy scores (as measured by the Brief 
Coping Orientation to Problems Experienced Inventory), and depression symptom severity 
scores (as measured by the Center for Epidemiologic Studies Depression Scale-Revised). That is, 
the severity of physical symptoms indicative of cardiac disease will be predicted by whether the 
individual perceives his or her social environment to be invalidating of his or her illness, the 
individual’s cognitive representation of the illness, whether the individual has used a positive 
coping strategy to manage distress, and whether the individual experiences elevated symptoms of 
depression. This hypothesis is based on previous research that has demonstrated a relationship 
between physical functioning and invalidation (Ghavidel-Parsa et al., 2014), IPs (Arran et al., 
2013), positive coping behaviors (Kaptein et al., 2006), and depression (Goldston & Baillie, 
2008).  
 Hypothesis 2: Coping mechanisms (as measured by the brief COPE) and depression 
symptom severity (as measured by the CESD-R) will both mediate the relationship between 
invalidation (as measured by scores on the 3*I) and physical functioning (as measured by a 
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composite score of the SF-36, heart rate, body mass index, and systolic blood pressure) as well 
as mediate the relationship between IP (as measured by the IPT) and physical functioning (as 
measured by a composite score of the SF-36, heart rate, body mass index, and systolic blood 
pressure). That is, the significance of the relationship between II and IP on physical functioning 
will be influenced by coping style and severity of depressive symptoms. This hypothesis is based 
on evidence that invalidation and IP appear to influence an individual’s coping style (Arran et 
al., 2013; Holohan, 1997), which appears to influence the severity of an individual’s depressive 
symptoms (Chiavarino et al., 2012), which appear to influence an individual’s level of physical 
functioning (Goldston & Baillie, 2008). Despite the absence of direct effects in Hypothesis 1, 
Hypothesis 2 was performed investigating mediation of all constructs in order to investigate 
opposing processes; that is, to investigate whether the	absence	of	direct	effects	is	the	result	of	inconsistent	mediation	of	other	constructs	involved	(Murayama	&	Elliot,	2012).		
Method 
Participants  
 This study utilized participants from the Cardiac Rehabilitation program at the Wellness 
Center of the University of South Carolina Aiken. A G*Power analysis revealed that in order to 
achieve statistically significant results, data from 44 participants would be required, which was 
achieved in the present study. Admission criteria for participation in the study consisted of the 
following criteria: a) a recent cardiac trauma in the form of myocardial infarction, coronary 
artery bypass graft surgery or percutaneous coronary intervention b) the ability to read at a level 
commensurate with the self-report measures employed in the study; and c) enrollment in the 
cardiac rehabilitation program. Rehabilitation members were not offered any compensation for 
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participating in the study, since the study was a review of assessments gathered during the 
rehabilitation program. 
Routine Measures 
Demographics Questionnaire (see Appendix A). A questionnaire was developed in order 
to ascertain important demographic information about each participant (i.e., gender, age, ethnic 
and cultural background, socioeconomic status, etc.) and the type of cardiac trauma experienced 
that led to enrollment in the cardiac rehabilitation program. Demographic information was 
assessed via forced-choice response options and the individual was asked to describe the cardiac 
event experienced and the date at which it occurred in an open-ended response. 
The 36-Item Short-Form Health Survey –3-month form SF-36; Ware & Sherbourne, 
1992; see Appendix B). The SF-36 is a 36-item survey of patient health consisting of a multi-
item scale that assesses eight health-related quality of life domains: limitations in physical 
functioning, limitations in usual role functioning because of physical health problems, bodily 
pain, general health perceptions, vitality, limitations in social functioning because of physical or 
emotional problems, limitations in usual role functioning because of emotional health problems, 
and general mental health. Each subscale contains statements relevant to a particular domain that 
are rated differently, depending on the domain being measured. For instance, questions assessing 
for limitations in physical activity are rated on a 3-point Likert scale where the individual is to 
indicate whether one’s health limits one’s physical activities (e.g., 1 = yes, limited a lot, 2 = yes, 
limited a little, 3 = no, not limited at all); in contrast, questions measuring vitality and mental 
health are to be rated on a 6-point Likert scale where feelings are to be rated in frequency over 
the past four weeks (e.g., 1 = all of the time, 2 = most of the time, 3 = a good bit of the time, 4 = 
some of the time, 5 = a little of the time, 6 = none of the time). The SF-36 has elicited high 
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internal consistency when used with patients suffering from a myocardial infarction with 
Cronbach alphas ranging from .72 to .92 (Failde & Ramos, 2000). Under each of the eight 
dimensions measured, item scores are coded, summed, and transformed to a scale ranging from 0 
(worst health status) to 100 (best health status). 
Scores on the SF-36 were combined with the patient’s heart	rate,	systolic	blood	pressure,	and	body	mass	index	data	into	one	overall	physical	functioning	composite	score.	First,	correlations	were	computed	between	all	variables	(Table	1).	It	is	important	to	note	that	the	SF-36	was	reverse	coded	in	order	to	compute	an	accurate	score	for	the	items,	and	thus	is	negatively	correlated	with	the	objective	physical	measures.	Each	raw	score	was	then	standardized	by	converting	it	into	a	z-score,	and	the	z-scores	were	then	summed	and	averaged	in	order	to	create	a	standardized	composite	for	physical	functioning	that	was	then	used	in	subsequent	analyses. 
The Center for Epidemiologic Studies Depression Scale- Revised (CESD-R; Eaton, 2004; 
Radloff, 1977; see Appendix C). The Center for Epidemiologic Studies Depression Scale is a 20-
item scale used to measure symptoms of depression in nine different groups as defined by the 
American Psychiatric Association Diagnostic and Statistical Manual, fifth edition. Using a 
forced-choice format, individuals were asked to rate on a 5-point Likert scale how often they 
experience symptoms (e.g. 0 = not at all or less than 1 day, 1 = 1-2 days, 2 = 3-4 days, 3 = 5-7 
days, and 4 = nearly every day for 2 weeks). These symptoms include sadness, loss of interest, 
appetite, sleep, concentration, guilt, tiredness, movement, and suicidal ideation. The total CESD-
R score was calculated as a sum of responses to all 20 questions and was used in determination 
of possible depressive symptom categories.  
The Brief Illness Perception Questionnaire (Brief IPQ; Broadbent, Petrie, Main, & 
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Weinman, 2006; see Appendix D). The Brief Illness Perception Questionnaire is a 9-item 
standardized instrument developed in order to assess cognitive and emotional illness 
representations. Eight items are rated on an 11-point (0-10) end-defined response scale. Five of 
the items assess cognitive illness representations: “consequences” (Item 1), “timeline” (Item 2), 
“the degree of personal control over the disease” (Item 3), “treatment control” (Item 4), and 
“identity” (Item 5). Two of the items assess emotional representations: “concern” (Item 6) and 
“emotional response” (Item 7), while one item assesses “illness understanding” (Item 8). High 
scores gained on these dimensions represent strongly-held beliefs about more serious 
consequences of the illness (Item 1), its more pronounced chronic nature (Item 2), stronger 
positive beliefs in controllability of the illness (Item 3 and 4), a greater number of symptoms 
attributed to the illness (Item 5), a higher level of patient’s emotional distress arising from the 
illness (Item 6 and 7), and better personal understanding of the illness (Item 8). 
The Brief Coping Orientation to Problems Experienced Inventory (Brief COPE; Carver, 
1997; Muller & Spitz, 2003; see Appendix E). The Brief COPE is a short, multidimensional 
inventory including 14 two-item scales that measure 14 conceptually differentiable coping 
reactions. These strategies, which include adaptive as well as potentially problematic responses, 
are acceptance, active coping, positive reframing, planning, using instrumental support, using 
emotional support, behavioral disengagement, self-distraction, self-blame, humor, denial, 
religion, venting, and substance use.  
The Illness Invalidation Inventory (3*I; Kool et al., 2010; see Appendix F). The 3*I is a 
40-item scale that assesses patients' perception of responses of others that are perceived as 
denying, lecturing, not supporting and not acknowledging the condition of the patient across five 
different sources. It assesses two internally consistent dimensions of invalidation: discounting 
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and lack of understanding. 
Duke Activity Status Index (DASI; Hlatky & Mark, 1989; see Appendix G). 
The Duke Activity Status Inventory is a 12-item questionnaire developed to measure 
functional status of the individual while also providing insight into selected aspects of quality of 
life. This scale uses the individual’s capacity in daily living activities in order to gauge functional 
capacity. These activities represent major aspects of physical functioning including: personal 
care, ambulation, ability to carry out household tasks, ability to engage in recreational activities, 
and ability to engage sexually. Participants were asked to indicate if and how well they could 
engage in each task, given one of four options, (1 = Yes, with no difficulty, 2 = Yes, but with 
some difficulty, 3 = No, I can’t do this, or 4 = Don’t do this for other reasons). The DASI has 
elicited high internal consistency when used with patients who have chronic coronary disease, 
with Cronbach alphas ranging from .81 to .89, while there were no statistically significant 
differences for stable patients in the two-week re-test period (Alonso et al., 1997). For every item 
listed on this measure, there is a corresponding weighted value (e.g., ability to walk around the 
house = 1.75; ability to run a short distance = 8.00) used for scoring purposes. In order to score 
the DASI, the total number of corresponding weighted values to all questions where the rater 
answered one (Yes, with no difficulty) is summed. In order to get the estimated peak oxygen 
uptake score, the summed number was entered into the following equation [0.43*(duke status 
index)] 9.6 and then divided by 3.5 to convert it into metabolic equivalents. Scores on the DASI 
may range from 0 – 52.8, with metabolic equivalent scores ranging from 0 – 9.89. Higher 
metabolic equivalent scores are indicative of a more physically active person with a 
corresponding higher functional capacity. In contrast, a low score on this measure indicates 
significant deficits in the ability to engage in physical activity and an overall poorer quality of 
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life. 
State-Trait Anxiety Inventory-Y-2 Form (STAI; Spielberger, Gorsuch, Lushene, 
Vagg, & Jacobs, 1983; see Appendix H). The STAI Y-Form serves as a measure of state (Y-1) 
and trait (Y-2) anxiety, and assesses the overall severity of anxiety in adults. Individuals rate on a 
4-point Likert scale how intensely they experience symptoms of anxiety at that moment while 
taking the assessment (e.g., 1 = Not at all, 2 = Somewhat, 3 = Moderately so, 4 = Very much so) 
and also generally speaking under normal circumstances (e.g., 1 = Almost never, 2 = Sometimes, 
3 = Often, 4 = Almost always). The instrument is divided into two sections, with each form 
having a total of twenty questions. The range of scores is 20-80, with a higher score indicating 
greater anxiety. Some of the questions assess for the absence of anxiety and therefore must be 
reverse-scored. For the purposes of this study, consistent with rehabilitation procedures, only the 
trait (Y-2) form was used. The test-retest reliability of the STAI was reported by Spielberger and 
colleagues (1970) to be .54 for the state measure and .86 for the trait measure. The STAI is 
considered a valid scale, with Cronbach’s alphas ranging from 0.87- 0.92 (Van der Ploeg, 
Defares, & Spielberger, 1970). 
Procedure	
All data was gathered from the cardiac rehabilitation program located at the USC Aiken 
Wellness Center. Within their first six sessions enrolled in the program, all rehabilitation 
participations were asked to complete routine assessments for the purposes of tracking 
rehabilitation progress. Patients completed the measures with a rehabilitation assistant at the 
cardiac rehabilitation facility. Patients were also given the option to take measures home with 
them to complete and return at their next session if they began to feel overwhelmed or fatigued. 
These routine assessments included the one-year 36-Item Short Form Health Survey (SF-36; 
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Ware & Sherbourne, 1992), the Brief Illness Perception Questionnaire (Brief IPQ; Broadbent, et 
al., 2006), the Brief Coping Orientation to Problems Experienced Inventory (Brief COPE; 
Carver, 1997; Muller & Spitz, 2003), the Illness Invalidation Inventory (3*1; Kool et al., 2010), 
the Duke Activity Status Index (DASI; Hlatky & Mark, 1989), the State-Trait Anxiety Inventory 
Y-1 form (STAI; Van der Ploeg, et al., 1980), and the Center for Epidemiologic Studies 
Depression Scale- Revised (CESD-R; Radloff, 1977; Eaton, 2004).  
Rehabilitation members were given the option to complete these assessments during one 
interview session or two based on their personal preference. Upon having completed the 
assessment paperwork, rehabilitation patients were provided feedback regarding their scores and 
will be offered appropriate referrals and supportive services as deemed necessary. Upon having 
completed the interview, all rehabilitation members were informed that they would be asked to 
return to fill out the routine exit assessments required by the rehabilitation program upon 
completion of the program.  
Results 
 Preliminary Analyses 
   A total of 44 individuals were enrolled in the cardiac rehabilitation program located at the 
USCA Wellness Center during data collection procedures. Of these 44 individuals, 25% were 
women (n=10) and 75% were men (n=34). One hundred percent (n=44) of the individuals 
reported their ethnicity as being Caucasian. The average age of participants was 72 years old, 
with ages ranging from 58 to 88 years old and a standard deviation of 7.8.  Of the 44 individuals 
who entered the program, 75% reported attending the cardiac rehabilitation program after having 
suffered a first-time cardiac event, and 25% reported having suffered one or more events prior to 
rehab enrollment. In regards to event type, 25% reported having a coronary stent implanted, 23% 
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reported having a heart attack, 21% reported having coronary artery bypass grafting, 16% 
reported having suffered multiple events, 11% reported having a valve replaced, 2% reported 
having bypass surgery, and 2% reported congestive heart failure. Demographic information 
describing rehabilitation members can be found in Table 2.  
   Means, standard deviations, and other descriptive statistics for data collected at entrance 
can be found in Table 3. IP, II, and Depression statistics were then organized by severity of 
cardiac event, which can be found in Table 4. Correlations	between	all	variables	were	computed	(Table	5).		There	was	a	strong,	positive	correlation	between	depression	and	IP,	
r(44)	=	0.52,	p	<	0.01.	There	was	a	moderate	negative	correlation	between	depression	and	physical	function,	r(44)	=	-	0.47,	p	<	0.01.	There	was	a	moderate,	positive	correlation	between	IP	and	II,	r(44)	=	0.48,	p	<	0.01,	and	a	moderate,	negative	correlation	between	IP	and	physical	functioning,	r(44)	=	-	0.41,	p	<	0.01.	Lastly,	there	was	a	moderate,	negative	correlation	between	II	and	physical	functioning,	r(44)	=	-	0.30,	p	<	0.05.	Additionally,	Cronbach’s	alpha	was	computed	to	determine	the	reliability	of	each	measure	(Table	6).	Thus	revealed	that	the	Brief	COPE	had	an	alpha	of	0.49,	the	IPQ	had	an	alpha	of	0.86,	the	3*I	had	an	alpha	of	0.90,	the	SF-36	had	an	alpha	of	0.82,	and	the	CESD-R	had	an	alpha	of	0.92.		
Hypothesis 1: Physical functioning will be predicted by IP, II, coping, and depression 
scores.  	
To	examine	the	extent	to	which	physical	functioning	could	be	explained	by	the	other	variables,	physical	functioning	was	regressed	onto	the	four	predictors	simultaneously:	Positive	coping,	IP,	invalidation,	and	depression	(Table	7).	The	overall	model	was	significant,	F(4,39)	=	3.68,	p	=	.012,	R2	=	.27,	indicating	that	27%	of	the	variance	in	physical	functioning	could	be	explained	by	the	set	of	predictors.	Inspection	of	each	predictor	
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individually	revealed	that	only	depression	had	a	significant	relationship	with	physical	functioning,	B	=	-.90,	p	=	.042.	Specifically,	each	1-unit	increase	in	depression	was	associated	with	a	.90	decrease	in	physical	functioning.		
Hypothesis 2: Positive coping and low depression scores will strengthen the relationship 
between invalidation and physical functioning and perception and physical functioning.  
  Results from Hypothesis 1 indicated that depression was the only significant predictor of 
physical functioning. In order to investigate Hypothesis 2, four mediation tests were performed. 
First	mediation	test	PROCESS	(Hayes,	2013)	was	used	in	order	to	test	whether	coping	mediated	the	relationship	between	invalidation	and	physical	functioning	(Figure	1).	The	overall	model	was	not	significant,	F(1,42)	=	1.32,	p	=0.26.	The	direct	effect	was	not	significant	(B=	-1.59,	
95%	CI	=	-3.24,	0.07,	p	=	0.06).	However,	this	effect	can	be	considered	marginally	significant	as	the	hypothesis	is	one-tailed.	The	indirect	effect	was	not	significant	(B	=	-0.07,	95%	CI	=	-0.45,	0.35).	
Second	mediation	test	Next,	the	same	procedure	was	used	to	test	whether	depression	mediated	the	relationship	between	invalidation	and	physical	functioning	(Figure	2).	The	direct	effect	was	not	significant	(B	=	0.98,	95%	CI	=	-2.54,	0.57,	p	=	0.21).	The	indirect	effect	was	not	significant	either	(B	=	-0.67,	95%	CI	=	-1.45,	0.29).	
Third	mediation	test		Mediational	analyses	were	performed	using	the	same	procedure	in	order	to	determine	whether	coping	mediated	the	effect	of	IP	on	physical	functioning	(Figure	3).	There	was	a	significant	direct	effect	(B	=	-0.75,	95%	CI	=	-1.27,	-.22,	p	=	0.01),	indicating	that	
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higher	IP	was	associated	with	lower	physical	functioning.	However,	the	indirect	effect	through	positive	coping	was	not	significant	(B	=	-0.01,	95%	CI	=	-0.13,	0.08).		
Fourth	mediation	test	Finally,	the	same	procedure	was	used	in	order	to	examine	whether	depression	would	mediate	the	relationship	between	IP	and	physical	functioning	(Figure	4).	The	direct	effect	was	not	significant	(B	=	-0.43,	95%	CI	=	-1.00,	0.15,	p	=	0.14).	Interestingly,	the	indirect	effect	was	indeed	significant	(B	=	-0.33,	95%	CI	=	-0.70,	-0.04).	 
Exploratory	Analyses	II	is	defined	as	encompassing	the	perception	of	cognitive,	affective	and	behavioral	responses	of	others	that	are	perceived	as	denying,	lecturing,	overprotecting,	not	supporting	and	not	acknowledging	with	respect	to	the	condition	of	the	patient	(Kool,	2012).	This	definition	suggests	that	II	may	be	related	to	the	patient’s	perception	of	his	or	her	illness	in	reference	to	others’	perceptions.		Thus,	a	second	exploratory	regression	analysis	was	performed	in	order	to	determine	whether	or	not	II	was	significantly	related	to	IP	(Table	8).	This	analysis	revealed	that	IP	was	significantly	related	to	II	in	the	cardiac	rehabilitation	population	(B	=0.48,	p	=	0.00).			Lastly,	based	on	these	significant	relationships	between	II	and	depression,	IP	and	depression,	and	II	and	IP,	PROCESS	was	used	in	order	to	investigate	whether	or	not	II	mediated	the	relationship	between	IP	and	depression	(Figure	5).		This	analysis	revealed	that	there	was	a	significant	direct	effect	(B	=	0.33,	95%	CI	=	0.12,	0.54,	p	=	0.00),	indicating	that	higher	IP	was	associated	with	higher	depression	scores.	However,	the	indirect	effect	through	invalidation	was	approaching	significance,	but	not	significant	(B	=	0.02,	95%	CI	=	-0.07,	0.21).		
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Discussion 
 
This study aimed to better understand the specific ways that II and IP are related to the 
severity of physical symptoms in cardiovascular rehabilitation patients. More specifically, this 
study examined the specific mechanisms involved in the relationship between II and physical 
functioning in cardiac rehabilitation patients and the specific mechanisms involved in the 
relationship between IP and physical functioning in cardiac rehabilitation patients. The present 
study first used regression analyses in order to determine the extent to which II, IP, coping and 
depression predicted physical functioning, and then by using PROCESS in order to identify 
potential mediators in these relationships. Furthermore, given the lack of understanding of how 
these relationships are mediated, the present study focused on how II and IPs are each 
individually related to coping behaviors and depressive symptoms, and how those constructs 
relate to patients’ physical functioning.  
Coping  
The first hypothesis that positive coping mechanisms would predict better physical 
functioning in a cardiac rehabilitation population was not supported in the present study. These 
results are contrary to previous research which has indicated that positive coping mechanisms 
including problem and emotion focused coping are predictive of better physical functioning after 
a cardiac trauma (Chiavarino et al., 2012).  However, most of these studies have looked at 
predictors of coronary heart disease in initially healthy samples and studied the development of 
heart disease over time, whereas the present study utilized participants already diagnosed and in 
rehabilitation for a heart condition. Thus, it is possible that participants in the present study may 
have already implemented changes in lifestyle or cognitions upon diagnosis of their heart 
condition; thus, the relationship between coping mechanisms and physical functioning during 
recovery may be different than the initial relationship between coping mechanisms and physical 
II	AND	IP	IN	THE	CONTEXT	OF	CARDIOVASCULAR	DISEASE	 28	
function during the development of the cardiac disease. This is consistent with previous literature 
suggesting that the question of whether illness perceptions influence well-being via coping or 
whether illness perceptions and coping each influence well-being independently should be 
investigated in further, preferably with longitudinal studies (Kaptein et al., 2006).  
It may also be the case that the presence of other psychosocial factors that were 
unaccounted for in this study may influence the relationship between coping and physical 
function.  For example, hostility, optimism, and other personality characteristics may play a role 
in physical health outcomes, and may also influence an individual’s style of coping (Shen et al., 
2003).  	 	 Sul and Fletcher (1985) found that active problem-focused coping was found to result in 
more benign long-term outcomes following cardiac events, and Ali et al. (2010) found that 
avoidant coping was associated with widespread psychological distress among cardiac patients, 
including depression.  In contrast, previous research indicates that using avoidance strategies to 
cope soon (two to three weeks) after a stressor occurred has been associated with higher levels of 
emotional distress (Dunkel-Schetter, Feinstein, Taylor, & Falke, 1992). Since measures were 
only administered at the beginning of the cardiac rehab process, patients may have been using 
those avoidant coping strategies for only a brief period of time, between when the cardiac trauma 
occurred and entrance into rehabilitation. Future research collecting data upon completion of the 
program may help to better illuminate effects of avoidant coping on physical functioning in 
patients over a longer time frame.   
  Further, results of Hypothesis 2 indicated that coping was not predicted by invalidation or 
IP. Thus, the expectation that positive coping strategies could be mediators in the relationships 
between IP and physical functioning and II and physical functioning seems unlikely. In 
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considering why coping strategies were not predicted by invalidation or IP, the self-regulation 
model proposed by Leventhal (1997) may be relevant. The self-regulation model assumes that 
health-related behavioral patterns such as coping strategies are a result of complex and 
comprehensive representations of illness (Leventhal, 1997). In addition to how the patient 
perceives the illness itself, multiple factors including the perceived consequences of the illness, 
perceived causes, timeline, and cure or control of the illness all contribute to behaviors and 
coping mechanisms an individual selects. It is also likely that an individual may not understand 
his or her illness to the fullest extent, and thus may not be able to appropriately select an 
effective coping strategy (Fan	et	al.,	2013).	Additionally, based on the significant relationship 
between invalidation and perception, it is not unreasonable to consider the likelihood of these 
numerous perception factors influencing an individual’s perceived invalidation from others, 
which is consistent with the definition provided by Kool (2012) that invalidation encompasses 
the perception of behavioral responses of others that are perceived as denying, lecturing, 
overprotecting, not supporting, and not acknowledging the patient’s condition. Consequently, 
coping strategies selected based on feelings of invalidation are unlikely to be consistent among 
individuals who may perceive their illnesses differently. This is consistent with previous studies, 
which suggest that patients plan and implement coping behaviors based on cognitive 
representations and emotional responses to their illness (Fan et al., 2012).  
  However, based on the low Cronbach’s alpha reliability score of the Brief COPE, it is 
most likely that the reason coping was not shown to be predictive of physical functioning, nor 
related to any other constructs is due to the low reliability score of the measure itself.  This low 
score is likely a result of using an overall coping score rather than reporting subscale scores to 
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look at different types of coping.  Future studies should note this and adjust administration of the 
measure accordingly.  
Depression			
As hypothesized, depression was significantly related to physical functioning in the 
cardiac rehabilitation population. This is consistent with previous studies that have found a 
significant relationship between depression and coronary heart disease (Carney et al., 2002; 
Goldston & Baillie, 2008; Rugulies, 2002). Analyses revealed that depression was also a 
significant mediator of the relationship between IP and physical functioning, which is consistent 
with previous studies that indicate that IP is related to emotional distress, and that emotional 
distress is related to depression (Arran et al., 2014; van den Broek et al., 2014). Meditational 
analyses used to test Hypothesis 2 revealed that when depression was tested as a mediator of the 
relationship between IP and physical functioning, the direct effect was not significant, but the 
indirect effect was. This	may	suggest	opposing	processes,	such	that	IPs	may	lead	to	behaviors	that	increase	physical	functioning	while	simultaneously	leading	to	depression,	which	decreases	physical	functioning	(Marayuma	&	Elliott,	2013).	However,	as shown in 
Table 3, II, IP, and depression were all significantly associated with health outcomes, thus, the 
probability of opposing processes is unlikely.  Furthermore, the regression analysis for 
Hypothesis 1 indicated that there was overlapping variation between the 3 constructs and that 
depression was the strongest, which was also evident in mediation analyses.   
The relationships between IP and depression, and between depression and physical 
functioning were also significant. Thus, results indicate that IP was significantly related to 
depression, and depression was significantly related to physical functioning. Therefore, an 
individual’s physical functioning may be related to his or her perception of the illness. This 
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perception may be related to emotional distress, which may be related to reduced physical 
functioning. This is consistent with findings from Hypothesis 1, which revealed	that	IP	did	not	significantly	predict	physical	functioning	in	this	cardiac	rehabilitation	sample.	These 
findings are contradictory to previous findings suggesting that IPs contribute directly to physical 
health (Kaptein et al., 2006).  However, previous findings also indicate that IPs affect physical 
health via coping mechanisms (Fan et al., 2010).  
An interesting finding is that when coping was tested as a mediator of the relationship 
between IP and physical functioning, the direct effect was significant, but the indirect effect was 
not. Thus, when coping was isolated as a mediator, IP was significantly related to physical 
functioning. Thus, it may be important to consider isolating these constructs in future studies in 
order to potentially identify causality and directionality.   
Contradictory to Hypothesis 2, the prediction that depression would mediate the 
relationship between invalidation and physical functioning was not supported. While considering 
the relationships between invalidation, depression, and physical health, previous research 
suggests that invalidation may impact physical health and social function but specific 
mechanisms as to how these constructs relate have not been defined (Ghavidel-Parsa et al., 
2014).  
However, while depression did not significantly mediate the relationship between 
invalidation and physical functioning, the relationship between invalidation and depression was 
significant, as was the relationship between depression and physical functioning. Thus, it is 
likely that an individual may have lower physical functioning if (s)he feels invalidated about his 
or her illness, and this invalidation may be related to emotional distress, including depressive 
symptoms, which are related to reduced physical functioning.  
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Additionally,	in	regards	to	II,	predictions	of	Hypothesis	1	that	invalidation	would	significantly	predict	physical	functioning	were	not	supported.	These	results	are 
contradictory to previous research suggesting that invalidation is significantly correlated with 
symptom severity and health status (Ghavidel-Parsal et al., 2014). However, to our knowledge, 
previous studies have investigated invalidation in the context of fibromyalgia and rheumatology 
(Ghavidel-Parsa et al., 2014; Kool, 2012) and this is the first study to investigate invalidation in 
relation to cardiac disease. Previous research has also separated invalidation into more specific 
constructs including discounting and lack of understanding, while this study used a total 
invalidation score. In addition, while previous research indicates that emotional distress is 
associated with lower physical functioning in cardiac patients (Hoogwegt et al., 2014). However, 
if a patient does not experience emotional distress as a result of invalidation, he or she may not 
experience a reduction in physical functioning. Thus, it may be possible that some patients can 
experience II, but may manage that invalidation in a way that does not result in emotional 
distress.  
Lastly, a	regression	analysis	was	performed	in	order	to	determine	if	II	may	be	related	to	the	patient’s	perception	of	his	or	her	illness	revealed	that	IPs	are	significantly	related	to	II.	Thus,	the	worse	an	individual	perceives	an	illness	to	be,	the	more	likely	it	is	that	this	will	be	related	to		higher	feelings	of	invalidation	from	others.	The	opposite	may	be	true	as	well,	as	it	is	possible	that	invalidation	may	be	related	to	illness	perceptions.	Future	studies	should	investigate	directionality	in	this	relationship.		Consistent	with	previous	findings	in	the	present	study,	this	suggests	that	IP	and	II	are	both	related	to	depression.	Due	to	the	significant	relationships	between	IP	and	II,	II	and	depression,	and	IP	and	depression,	a	mediation	analysis	was	performed	in	order	to	determine	if	II	might	mediate	
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the	relationship	between	IP	and	depression.	This	relationship	was	not	found	to	be	approaching	significance.		 
Strengths and Limitations 
  First, this study used PROCESS in order to investigate the interrelationships among 
multiple variables that, to our knowledge, have not been previously connected in the health 
literature. Additionally, to the best of our knowledge, this was the first study to investigate the 
construct of illness invalidation in relation to a cardiac rehabilitation population, as almost all 
previous studies have examined II in relation to rheumatology diseases. Likewise, it is the first of 
its kind to investigate IP in a cardiac setting, and the relationship between IP, depression, and 
physical health can prove extremely beneficial in future health interventions.  
Although there were several novel findings within the present study, there were also 
several limitations, which should be addressed in future studies. One limitation was the 
demographic composition, which had very little variability. For example, the sample was 
comprised of 44 participants enrolled in a cardiac rehabilitation program located in a small 
southeastern community, and thus may not be fully representative of the full range of beliefs and 
experiences of those differing geographic regions or with different medical diagnoses. It should 
also be noted that the sample size was relatively small with only 44 participants, who were 
mostly white males of high socioeconomic status. While the results of the present study may be 
generalizable to populations with similar demographic composition who have experienced a 
cardiac event, caution should be taken in generalizing the results to other types of medical illness 
or the larger population due to representativeness issues. Thus, future studies should make a 
more determined effort to increase the number of racially diverse participants as it is necessary to 
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determine whether patterns established in the empirical findings in the present study may pertain 
more so to non-minorities than they do to minorities.  
Additionally, due to the nature of the cardiac rehabilitation population, it is likely that the 
sample did not include individuals who were employing completely avoidant coping strategies, 
as all individual enrolled in the program were implementing some level of active coping by 
attending the program. Thus, it is likely that the sample did not include patients with a 
completely avoidant style of coping.  
It is possible that participants may not have responded in a forthright manner given that 
measures were first completed upon entrance into the program, when participants may have felt 
particularly self-conscious about their physical abilities or symptoms of distress. Participants also 
reported feeling overwhelmed with the amount of measures administered, and thus may not have 
taken the time to answer honestly and accurately. Therefore, future research may benefit from 
the use of alternative measurement techniques, such as personal interviews, administered over a 
period of days rather than all at once. With this said, however, participants provided information 
voluntarily and had the option to leave blank any question or form they felt uncomfortable 
answering. Thus, this limitation is not seen as particularly problematic, given that data was 
collected through standard protocol, as utilized by the cardiac rehabilitation program.  
Finally, another limitation relates to the fact that previous non-cardiac traumas were not assessed 
for in the context of constructs examined. While all individuals in the present study share a 
cardiac history, it should be noted that we cannot rule out the effects of other potential traumas or 
stressors on reports of physical functioning or the overall findings.  
Summary and Conclusions 
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In conclusion, this study provided an in-depth examination of the characteristics 
associated with and predictive of physical functioning in a cardiac rehabilitation sample. To the 
best of our knowledge, this was the first study to examine the relationships between II, IP, 
coping mechanisms, depression, and physical functioning together.  Previous studies indicated 
that all of these constructs may be related, but the specific mechanisms were not clear. The 
present study used a regression analysis to reveal that depression was the only significant 
predictor of physical functioning, and that II, IP, and coping were not. The present study also 
used PROCESS to reveal that depression mediated the relationship between IP and physical 
functioning, but did not mediate the relationship between II and physical functioning. The 
present study failed to find evidence that coping mediated the relationship between IP and 
physical functioning, nor did coping mediate the relationship between II and physical 
functioning. The present study also revealed that IP and II were significantly related to 
depression, and that IP was significantly related to II. Thus, the present study suggests that II, IP, 
depression, and physical functioning are all related. Findings indicate that the more threatening a 
patient perceives an illness to be is related to the patient experiencing more depressive 
symptoms. The study also suggests that the more depressive symptoms a patient experiences is 
related to the patient experiencing a reduction in physical functioning. Findings also imply that 
the more threatening a patient perceives an illness to be is related to the patient experiencing 
invalidation from others about his or her illness. Lastly, the present study suggests that the more 
invalidated a patient feels in relation to his or her illness is related to the depressive symptoms 
the patient experiences as well. Thus, II, IP, and depression all clearly play an important 
functional role in the maintenance of physical functioning in a cardiac rehabilitation population.   
Implications and Directions for Future Research 
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While all predictions of the study were not fully supported, the present study did reveal 
some interesting findings. First, results from the present study have better illuminated how the 
constructs of depression, coping, II, IP, and physical function are related. While the present study 
did not support the prediction that II, IP, and coping would each predict physical functioning, 
these results may indicate that these constructs are more closely related to physical functioning 
during development of disease, rather than after the patient has already entered a rehabilitation 
program.  This is especially important for future health interventions, as findings indicate that 
these constructs may only be predictive of physical health before a detrimental health even 
occurs. These results also indicated that not only is depression related to physical functioning as 
indicated in previous literature (Carney et al., 2002; Rugulies, 2002), but illuminates the 
interrelationships among other variables that are related to depression and physical functioning 
as well. IP and II were both found to be related to depression, which is related to physical 
functioning, and IP was related to II. This is especially important in development of future 
treatment plans, as focusing on not only the patient’s perception of his or her illness, but how 
that perception may contribute to feelings of invalidation or depressive symptoms that may 
contribute to the patient’s overall health. Additionally, it may be beneficial to include behavioral 
observation of the patient with his or her support system in order to objectively observe the 
degree of invalidation.  
 Given these different associations between II and IP and physical functioning, the use of 
strategies aimed at teasing apart causal relationships among these variables may help increase 
physical functioning in cardiac rehab patients. For example, working with patients’ significant 
others and families in order to help them better understand the patient’s illness and symptoms, 
and also educating them about how invalidation my manifest physically, as is also likely that an 
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individual may not understand his or her illness to the fullest extent, and thus may not be able to 
appropriately select an effective coping strategy (Kool, 2012; Fan et al., 2013). Lastly, future 
methods should also assess individuals’ perception of the illness in a more in-depth manner, as 
perception is likely influenced by numerous factors unaccounted for in this study.  
 In addition to treatment related suggestions, methodological suggestions for future 
research are important to consider as well. It may be relevant to separate the physical functioning 
construct into objective health measures (BMI, heart rate, and systolic blood pressure), and the 
SF-36, which is a more subjective measure. It would also be important to administer only the 
active coping items on the Brief COPE rather than administering all items and generating an 
overall coping score. Additionally, it would be helpful to obtain data from a more diverse 
rehabilitation population in order to create a more generalizable result. It would also be ideal to 
collect data on patients before a cardiac trauma occurs or the patient is diagnosed with a cardiac 
disease, in order to determine the extent to which, if any, coping, depression, II, and IP predict 
the development of a cardiac trauma or cardiac disease. Lastly, future research may benefit from 
using a sample of all individuals diagnosed with a cardiac disease, rather than simply those who 
attend cardiac rehabilitation in order to achieve a more accurate representation of the population, 
as individuals who attend cardiac rehabilitation already have achieved a somewhat active level of 
coping since they are in a program designed to help them recover from and manage their disease. 
It would also be beneficial to make more of an effort to help patients understand the purpose of 
the measures so that they may be more likely to respond in a more truthful and forthright 
manner. 
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Table 1 
Summary of Intercorrelations of Physical Variables 
 1 2 3 
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1. SF-36 --- --- --- 
2. Heart Rate -0.51** --- --- 
3. BMI -0.63** 0.65* --- 
4. Blood Pressure  -0.57* 0.96* 0.54* 
Note: *p <.05,**p <.01. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 
Participant	Demographics	(N=44)		Variables	 	 	 	 	 										n		 	 				Percent	
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Table 4 
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Summary of Regression Predicted by Severity of Event  
 
Variable 
 
B 
 
SE (B) 
 
β 
Depression 0.79 1.92 0.06 
Coping 0.45 0.24 0.27 
Invalidation 0.91 0.94 0.15 
Perception 1.58 2.80 0.09 
R2  .07  
F-value              3.36*  
Note: *p < .05; Event severity was separated into three categories that were used as predictors: Category 1: Other, 
stent; Category 2: MI, CHF; Category 3: CABG, multiple events  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5 
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Summary of Intercorrelations of Variables 
 1 2 3 4 
1. Positive Coping --- --- --- --- 
2. Depression 0.15 --- --- --- 
3. IP 0.06 0.52** --- --- 
4. Invalidation 0.18 0.29 0.48** --- 
5. Physical Function -0.12 -0.47** -0.41** -0.30* 
Note: *p <.05,**p <.01. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table	6	
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Summary	of	Reliability	Statistics	for	Measures		
 Cronbach’s Alpha 
1. Brief COPE 0.49 
2. IP 0.86 
3. Invalidation 0.90 
2. SF-36 0.82 
3. CESD-R 0.92 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7 
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Summary of Regression Analysis: Predicting for Physical Functioning 
  
 
Variable 
 
B 
 
SE (B) 
 
β 
Depression -0.90 0.04 -0.34* 
Coping -0.76 2.50 -0.19 
Invalidation -0.58 0.86 -0.11 
Perception -0.34 0.32 -0.19 
R2  .27  
F-value              3.68*  
Note: *p < .05, **p < .01. 
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Table 8 
Summary of Regression Analysis: Predicting for II 
  
 
Variable 
 
B 
 
SE (B) 
 
β 
Perception 0.16 0.46 0.48** 
R2  0.21  
F-value              12.6**  
Note: *p < .05, **p < .01. 	
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Figure 1: Coping as a mediator of the relationship between II and physical function 
 
 
Note: *p < .05; **p < .01. Effects of increased invalidation on physical function through the potential mediator of 
coping; coefficients are unstandardized estimates and the coefficient in parentheses is the total effect.  
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Figure 2: Depression as a mediator of the relationship between II and physical function 
 
 
 
Note: *p < .05; **p < .01. Effects of increased invalidation on physical function through the potential mediator of 
depression; coefficients are unstandardized estimates and the coefficient in parentheses is the total effect.  
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Figure 3: Coping as a mediator of the relationship between IP and physical function 
 
 
Note: *p < .05; **p < .01. Effects of worse IP on physical function through the potential mediator of coping; 
coefficients are unstandardized estimates and the coefficient in parentheses is the total effect.  
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Figure 4: Depression as a mediator of the relationship between IP and physical function 
 
 
Note: *p < .05; **p < .01. Effects of worse IP on physical function through the potential mediator of depression; 
coefficients are unstandardized estimates and the coefficient in parentheses is the total effect.  
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Figure 5: II as a mediator of the relationship between IP and depression 
 
 
Note: *p < .05; **p < .01. Effects of worse IP on depression through the potential mediator of invalidation; 
coefficients are unstandardized estimates and the coefficient in parentheses is the total effect.  	
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Appendix A 
Demographics Questionnaire 
Please answer the following questions to the best of your ability.  
 
What is your gender? 
Male  Female  
 
What is your race/ethnicity?  
Caucasian 
African American 
Asian  
Other  
 
What is your current marital status? 
Single  
Married  
Divorced  
Widowed  
Separated  
 
What is your current employment status? 
Employed  
Unemployed  
Retired  
Unable to work  
 
What is your current annual household income? 
$0 – 19,999  
$20 – 39,999  
$40 – 59,999  
$60 – 79,999  
$ 80,000+  
N/A  
 
Please describe your cardiac event that brought you to the cardiac rehabilitation program:  
______________________________________________________________________________
__________________________________________________________________ 
______________________________________________________________________________
__________________________________________________________________ 
______________________________________________________________________________
__________________________________________________________________ 
______________________________________________________________________________
__________________________________________________________________ 
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Have you ever attended cardiac rehabilitation in the past?  
No previous rehabilitation 
Yes, completed previous rehabilitation program  
Yes but dropped out  
 
Have you ever had a previous cardiac event? 
No, no previous event  
Yes, cardiac history  
 
If yes, please describe: 
______________________________________________________________________________
__________________________________________________________________ 
______________________________________________________________________________
__________________________________________________________________ 
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Appendix C 
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Appendix D 
Brief IPQ 
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Appendix E 
 
Brief COPE 
 
These items deal with ways you've been coping with the stress in your life since you found out you were 
going to have to have this operation. There are many ways to try to deal with problems. These items ask 
what you've been doing to cope with this one. Obviously, different people deal with things in different 
ways, but I'm interested in how you've tried to deal with it. Each item says something about a particular 
way of coping. I want to know to what extent you've been doing what the item says. How much or how 
frequently. Don't answer on the basis of whether it seems to be working or not—just whether or not you're 
doing it. Use these response choices. Try to rate each item separately in your mind from the others. Make 
your answers as true FOR YOU as you can. 
 
 1 = I haven't been doing this at all  
 2 = I've been doing this a little bit  
 3 = I've been doing this a medium amount  
 4 = I've been doing this a lot 
 
1. I've been turning to work or other activities to take my mind off things.  
2. I've been concentrating my efforts on doing something about the situation I'm in.  
3. I've been saying to myself "this isn't real.".  
4. I've been using alcohol or other drugs to make myself feel better.  
5. I've been getting emotional support from others.  
6. I've been giving up trying to deal with it.  
7. I've been taking action to try to make the situation better.  
8. I've been refusing to believe that it has happened.  
9. I've been saying things to let my unpleasant feelings escape.  
10. I’ve been getting help and advice from other people.  
11. I've been using alcohol or other drugs to help me get through it.  
12. I've been trying to see it in a different light, to make it seem more positive.  
13. I’ve been criticizing myself.  
14. I've been trying to come up with a strategy about what to do.  
15. I've been getting comfort and understanding from someone.  
16. I've been giving up the attempt to cope.  
17. I've been looking for something good in what is happening.  
18. I've been making jokes about it.  
19. I've been doing something to think about it less, such as going to movies, watching    TV, reading, 
daydreaming, sleeping, or shopping.  
20. I've been accepting the reality of the fact that it has happened.  
21. I've been expressing my negative feelings.  
22. I've been trying to find comfort in my religion or spiritual beliefs.  
23. I’ve been trying to get advice or help from other people about what to do.  
24. I've been learning to live with it.  
25. I've been thinking hard about what steps to take.  
26. I’ve been blaming myself for things that happened.  
27. I've been praying or meditating.  
28. I've been making fun of the situation. 
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Appendix F 
Illness Invalidation Inventory 
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Appendix G 
Duke Activity Status Index 
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Appendix H 
State Trait Anxiety Inventory form Y-2 
 
